Side effect management algorithms for niraparib/abiraterone acetate in prostate cancer.
These algorithms are intended to provide practical assistance to Canadian clinicians managing the most common AEs encountered with the novel combination, niraparib/AA+P, for mCRPC.
Authors
- Margot K. Davis (ORCID: https://orcid.org/0000-0001-7367-8267)
- Jenny J. Ko (ORCID: https://orcid.org/0000-0002-9286-2673)
- Geoffrey Gotto (ORCID: https://orcid.org/0000-0001-6637-2032)
- Jean-Baptiste Lattouf
- Christian Constance
Institutions
- University of British Columbia (CA)
Publication Details
- Journal
- PubMed
- Published
- 2024-10-01
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00